Joseph Piepmeier, MD, FAANS
Research & Publications
Biography
News
Research Summary
Yale's neuro-oncology program puts together all of the components
critical to managing patients with brain tumors: comprehensive evaluation
and diagnosis, leading edge treatment options, thorough follow-up and
psychosocial support. Patients are welcome whether they are newly diagnosed
or have already received extensive treatment.
Calls from referring physicians, patients or their families are handled
by an experienced clinical care coordinator. The coordinator ensures that
appropriate appointments are made quickly. New patients with brain tumors
are usually seen in the oncology clinic of the Yale Cancer Center within
a couple of days. The care coordinator also acts as the patient's interface
with the various medical specialists who are called into play in each
treatment plan.
The patient is the focus of all of the diagnosis and treatment skills Yale's interdisciplinary team of specialists brings to the service. Neuro-oncology surgeons, radiation oncologists, neuroradiologists, medical oncologists, neurologists, neuropathologists and others meet weekly at a Tumor Board Conference to arrive at the most appropriate treatment plan for each individual. Because the Yale Cancer Center is an academic referral center, the teams of specialists have an opportunity to treat the rarest as well as the most common cancers. Because of the center's research and teaching mission, its practitioners are well acquainted with the most advanced treatment methods. Patients benefit from that knowledge and from specialized resources such as a dedicated neurological intensive care unit and the latest imaging technologies.
Specialized Terms: Neuro-oncology; Acoustic neuroma; Brain tumor; Stereotactic needle biopsy
Coauthors
Research Interests
Biopsy, Needle; Brain Neoplasms; Neoplasms; Nervous System Diseases; Neuroma, Acoustic; Neurosurgery; Diseases
Research Images
Selected Publications
- NIMG-105. DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMASKim L, De Feyter H, de Graaf R, Fulbright R, Liu Y, Rothman D, Baehring J, Blondin N, Kim P, Omuro A, Chiang V, Moliterno J, Omay S, Piepmeier J, Corbin Z. NIMG-105. DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMAS. Neuro-Oncology 2022, 24: vii189-vii189. PMCID: PMC9660955, DOI: 10.1093/neuonc/noac209.723.
- Primary melanotic tumors of the nervous system: a consecutive case seriesGrosshans H, Huttner A, Piepmeier J, Kaulen L, Fulbright R, Baehring J, Karschnia P. Primary melanotic tumors of the nervous system: a consecutive case series. European Journal Of Neurology 2020, 27: 2303-2307. PMID: 32654331, DOI: 10.1111/ene.14437.
- Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience.Karschnia P, Barbiero FJ, Schwaiblmair MH, Kaulen LD, Piepmeier JM, Huttner AJ, Becker KP, Fulbright RK, Baehring JM. Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience. Neuro-Oncology Practice 2019, 7: 118-126. PMID: 32257290, PMCID: PMC7104875, DOI: 10.1093/nop/npz020.
- SURG-03. A COMPARISON OF SURVIVAL OUTCOMES AFTER BIOPSY VERSUS RESECTION IN PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTION EXPERIENCEHong C, Barbiero F, Chiang V, Moliterno J, Piepmeier J, Corbin Z, Baehring J. SURG-03. A COMPARISON OF SURVIVAL OUTCOMES AFTER BIOPSY VERSUS RESECTION IN PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE. Neuro-Oncology 2018, 20: vi250-vi250. PMCID: PMC6216251, DOI: 10.1093/neuonc/noy148.1039.
- Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial.Lester-Coll N, Supko J, Kluytenaar J, Pavlik K, Yu J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Contessa J, Ramani R, Lampert R, Yao X, Bindra R. Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial. Journal Of Clinical Oncology 2018, 36: e14046-e14046. DOI: 10.1200/jco.2018.36.15_suppl.e14046.
- Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion TrialLester-Coll N, Kluytenaar J, Pavlik K, Yu J, Contessa J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Ramani R, Lampert R, Yao X, Bindra R. Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion Trial. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s93. DOI: 10.1016/j.ijrobp.2016.06.233.
- Recurrent somatic mutations in POLR2A define a distinct subset of meningiomasClark VE, Harmancı AS, Bai H, Youngblood MW, Lee TI, Baranoski JF, Ercan-Sencicek AG, Abraham BJ, Weintraub AS, Hnisz D, Simon M, Krischek B, Erson-Omay EZ, Henegariu O, Carrión-Grant G, Mishra-Gorur K, Durán D, Goldmann JE, Schramm J, Goldbrunner R, Piepmeier JM, Vortmeyer AO, Günel JM, Bilgüvar K, Yasuno K, Young RA, Günel M. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nature Genetics 2016, 48: 1253-1259. PMID: 27548314, PMCID: PMC5114141, DOI: 10.1038/ng.3651.
- Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and ImagingHan L, Kong DK, Zheng MQ, Murikinati S, Ma C, Yuan P, Li L, Tian D, Cai Q, Ye C, Holden D, Park JH, Gao X, Thomas JL, Grutzendler J, Carson RE, Huang Y, Piepmeier JM, Zhou J. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging. ACS Nano 2016, 10: 4209-4218. PMID: 26967254, PMCID: PMC5257033, DOI: 10.1021/acsnano.5b07573.
- ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIALLester-Coll N, Kluytenaar J, Pavlik K, Yu J, Contessa J, Moliterno J, Piepmeier J, Becker K, Baehring J, Huttner A, Vortmeyer A, Ramani R, Lampert R, Yao X, Bindra R. ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL. Neuro-Oncology 2015, 17: v13-v13. PMCID: PMC4638537, DOI: 10.1093/neuonc/nov205.15.
- Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonanceStrohbehn G, Coman D, Han L, Ragheb RR, Fahmy TM, Huttner AJ, Hyder F, Piepmeier JM, Saltzman WM, Zhou J. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance. Journal Of Neuro-Oncology 2014, 121: 441-449. PMID: 25403507, PMCID: PMC4323763, DOI: 10.1007/s11060-014-1658-0.
- Abstract A86: Preclinical refinement of a highly-penetrative polymeric nanoparticle drug delivery system for the treatment of glioblastoma multiforme.Strohbehn G, Atsina K, Patel T, Piepmeier J, Zhou J, Saltzman W. Abstract A86: Preclinical refinement of a highly-penetrative polymeric nanoparticle drug delivery system for the treatment of glioblastoma multiforme. Molecular Cancer Therapeutics 2013, 12: a86-a86. DOI: 10.1158/1535-7163.targ-13-a86.
- Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaZhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, Zhang Y, Sullivan DJ, Piepmeier JM, Saltzman WM. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 11751-11756. PMID: 23818631, PMCID: PMC3718184, DOI: 10.1073/pnas.1304504110.
- Clinical Presentation in Diffuse Low-Grade GliomasTorres-Reveron J, Piepmeier J, Becker K. Clinical Presentation in Diffuse Low-Grade Gliomas. 2013, 179-188. DOI: 10.1007/978-1-4471-2213-5_12.
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMOClark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Özduman K, Avşar T, Li J, Murray PB, Henegariu O, Yilmaz S, Günel JM, Carrión-Grant G, Yılmaz B, Grady C, Tanrıkulu B, Bakırcıoğlu M, Kaymakçalan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilgüvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, Kılıç T, Lifton RP, Noonan JP, Yasuno K, Günel M. Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013, 339: 1077-1080. PMID: 23348505, PMCID: PMC4808587, DOI: 10.1126/science.1233009.
- Abstract A21: High-throughput small molecule screening of genetically diverse glioblastoma stem cellsStrohbehn G, Zhou J, Fu M, Patel T, Piepmeier J, Saltzman W. Abstract A21: High-throughput small molecule screening of genetically diverse glioblastoma stem cells. Cancer Research 2012, 72: a21-a21. DOI: 10.1158/1538-7445.csb12-a21.
- Low-Grade Gliomas When and How to TreatOmay SB, Piepmeier JM, Knisely JP. Low-Grade Gliomas When and How to Treat. Hematology/Oncology Clinics Of North America 2012, 26: 797-809. PMID: 22794284, DOI: 10.1016/j.hoc.2012.05.001.
- Role of Neurosurgery and Radiation Therapy in the Management of Brain TumorsPatel TR, Yu JB, Piepmeier JM. Role of Neurosurgery and Radiation Therapy in the Management of Brain Tumors. Hematology/Oncology Clinics Of North America 2012, 26: 757-777. PMID: 22794282, DOI: 10.1016/j.hoc.2012.04.001.
- Giant myofibroma of the orbit in an adult male.Servat JJ, Williamson JE, Piepmeier J, Sinard J, Bernardino CR. Giant myofibroma of the orbit in an adult male. Orbit (Amsterdam, Netherlands) 2012, 31: 21-3. PMID: 22007896, DOI: 10.3109/01676830.2011.605501.
- Neurosurgical ApproachMoliterno JA, Patel TR, Piepmeier JM. Neurosurgical Approach. The Cancer Journal 2012, 18: 20-25. PMID: 22290253, DOI: 10.1097/ppo.0b013e3183243f6e3.
- Chapter 27 Surgical Approaches to Lateral and Third Ventricular TumorsPatel T, Gould G, Baehring J, Piepmeier J. Chapter 27 Surgical Approaches to Lateral and Third Ventricular Tumors. 2012, 330-338. DOI: 10.1016/b978-1-4160-6839-6.10027-9.
- Polymeric nanoparticles for drug delivery to the central nervous systemPatel T, Zhou J, Piepmeier JM, Saltzman WM. Polymeric nanoparticles for drug delivery to the central nervous system. Advanced Drug Delivery Reviews 2011, 64: 701-705. PMID: 22210134, PMCID: PMC3323692, DOI: 10.1016/j.addr.2011.12.006.
- Biodegradable poly(amine-co-ester) terpolymers for targeted gene deliveryZhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, Jiang Z, Saltzman WM. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nature Materials 2011, 11: 82-90. PMID: 22138789, PMCID: PMC4180913, DOI: 10.1038/nmat3187.
- Chapter 123 Unusual GliomasDiluna M, Baehring J, Huttner A, Piepmeier J. Chapter 123 Unusual Gliomas. 2011, 1341-1350.e1. DOI: 10.1016/b978-1-4160-5316-3.00126-x.
- Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumorsSawyer AJ, Saucier-Sawyer JK, Booth CJ, Liu J, Patel T, Piepmeier JM, Saltzman WM. Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors. Drug Delivery And Translational Research 2010, 1: 34-42. PMID: 21691426, PMCID: PMC3117592, DOI: 10.1007/s13346-010-0001-3.
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastomaKunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro-Oncology 2010, 12: 871-881. PMID: 20511192, PMCID: PMC2940677, DOI: 10.1093/neuonc/nop054.
- Anaplastic oligoastrocytoma in Turcot syndromeBaehring J, Hui P, Piepmeier J, Bannykh SI. Anaplastic oligoastrocytoma in Turcot syndrome. Journal Of Neuro-Oncology 2009, 95: 293-298. PMID: 19495563, DOI: 10.1007/s11060-009-9928-y.
- The future of neuro-oncologyPiepmeier JM. The future of neuro-oncology. Acta Neurochirurgica 2009, 151: 1343. PMID: 19639245, DOI: 10.1007/s00701-009-0471-6.
- Primary, non-exophytic, optic nerve germ cell tumorsDiLuna ML, Two AM, Levy GH, Patel T, Huttner AJ, Duncan CC, Piepmeier JM. Primary, non-exophytic, optic nerve germ cell tumors. Journal Of Neuro-Oncology 2009, 95: 437-443. PMID: 19554263, DOI: 10.1007/s11060-009-9941-1.
- Current concepts in the evaluation and management of WHO grade II gliomasPiepmeier JM. Current concepts in the evaluation and management of WHO grade II gliomas. Journal Of Neuro-Oncology 2009, 92: 253-259. PMID: 19357953, DOI: 10.1007/s11060-009-9870-z.
- PrefacesAndrews DW, Yu C, Gutin PH, Piepmeier JM. Prefaces. Neurosurgery 2009, 64: a2-a6. PMID: 19165070, DOI: 10.1227/01.neu.0000312702.38535.d4.
- Prefaces.Andrews DW, Yu C, Gutin PH, Piepmeier JM. Prefaces. Neurosurgery 2009, 64: A2-A6. PMID: 28173313, DOI: 10.1227/01.NEU.0000312702.38535.D4.
- Intracranial benign fibrous histiocytomas: a case report and reviewMoliterno JA, Sood S, Zambrano E, Kim JH, Piepmeier JM, Baehring JM. Intracranial benign fibrous histiocytomas: a case report and review. Journal Of Neuro-Oncology 2008, 92: 203-209. PMID: 19030779, DOI: 10.1007/s11060-008-9743-x.
- Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain.Ozduman K, Wollmann G, Piepmeier JM, van den Pol AN. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience 2008, 28: 1882-93. PMID: 18287505, PMCID: PMC6671450, DOI: 10.1523/JNEUROSCI.4905-07.2008.
- Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study GroupKunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK. Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group. Journal Of Clinical Oncology 2007, 25: 837-844. PMID: 17327604, DOI: 10.1200/jco.2006.08.1117.
- New methods for direct delivery of chemotherapy for treating brain tumors.Sawyer AJ, Piepmeier JM, Saltzman WM. New methods for direct delivery of chemotherapy for treating brain tumors. The Yale Journal Of Biology And Medicine 2006, 79: 141-52. PMID: 17940624, PMCID: PMC1994797.
- The Interactions of Polarographic Measurements of Oxygen Tension and Histological Grade in Human GliomaLally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, Knisely JP. The Interactions of Polarographic Measurements of Oxygen Tension and Histological Grade in Human Glioma. The Cancer Journal 2006, 12: 461-466. PMID: 17207315, DOI: 10.1097/00130404-200611000-00005.
- Diffusion MRI in the early diagnosis of malignant gliomaBaehring JM, Bi WL, Bannykh S, Piepmeier JM, Fulbright RK. Diffusion MRI in the early diagnosis of malignant glioma. Journal Of Neuro-Oncology 2006, 82: 221-225. PMID: 17029014, DOI: 10.1007/s11060-006-9273-3.
- 21‐YEAR‐OLD WOMAN WITH A CYSTIC BRAIN LESIONDotto JE, Baehring J, Piepmeier JM, Bannykh SI. 21‐YEAR‐OLD WOMAN WITH A CYSTIC BRAIN LESION. Brain Pathology 2006, 16: 239-241. PMID: 16911483, PMCID: PMC8095829, DOI: 10.1111/j.1750-3639.2006.00014_3.x.
- Chondrosarcoma of the Skull BaseBaehring JM, Piepmeier J, Duncan C, Liebsch N, Ogle E, Kim J. Chondrosarcoma of the Skull Base. Journal Of Neuro-Oncology 2006, 76: 49-49. PMID: 16402277, DOI: 10.1007/s11060-005-5981-3.
- CommentsPiepmeier J. Comments. Neurosurgery 2005, 57: s4-4-s4-4. DOI: 10.1093/neurosurgery/57.suppl_5.s4-4.
- Transcallosal Transchoroidal Approach to Tumors of the Third VentricleKasowski HJ, Nahed BV, Piepmeier JM. Transcallosal Transchoroidal Approach to Tumors of the Third Ventricle. Neurosurgery 2005, 57: ons-361-ons-366. PMID: 16234686, DOI: 10.1227/01.neu.0000176652.59747.40.
- Novel Tumor-Specific Isoforms of BEHAB/Brevican Identified in Human Malignant GliomasViapiano MS, Bi WL, Piepmeier J, Hockfield S, Matthews RT. Novel Tumor-Specific Isoforms of BEHAB/Brevican Identified in Human Malignant Gliomas. Cancer Research 2005, 65: 6726-6733. PMID: 16061654, DOI: 10.1158/0008-5472.can-05-0585.
- Surgical resection for patients with benign primary brain tumors and low grade gliomasPiepmeier J, Baehring J. Surgical resection for patients with benign primary brain tumors and low grade gliomas. Journal Of Neuro-Oncology 2004, 70: 371-371. DOI: 10.1007/s11060-004-5898-2.
- Tumors of the posterior third ventricle and pineal region: ependymoma and germinomaBaehring J, Vives K, Duncan C, Piepmeier J, Bannykyh S. Tumors of the posterior third ventricle and pineal region: ependymoma and germinoma. Journal Of Neuro-Oncology 2004, 70: 273-274. PMID: 15674486, DOI: 10.1007/s11060-004-5395-7.
- MelanocytomaBannykh S, Piepmeier J, Baehring J. Melanocytoma. Journal Of Neuro-Oncology 2004, 70: 35-35. PMID: 15527105, DOI: 10.1023/b:neon.0000040895.76760.69.
- The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissueLALLY B, ROCKWELL S, FISCHER D, COLLINGRIDGE D, PIEPMEIER J, KNISELY J. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissue. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s194-s194. DOI: 10.1016/s0360-3016(04)01190-3.
- The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissueLally B, Rockwell S, Fischer D, Collingridge D, Piepmeier J, Knisely J. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissue. International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s194. DOI: 10.1016/j.ijrobp.2004.06.133.
- Surgical Resection for Patients with Benign Primary Brain Tumors and Low Grade GliomasPiepmeier J, Baehring JM. Surgical Resection for Patients with Benign Primary Brain Tumors and Low Grade Gliomas. Journal Of Neuro-Oncology 2004, 69: 55-65. PMID: 15527080, DOI: 10.1023/b:neon.0000041871.46785.53.
- Non-enhancing de novo glioblastoma: report of two casesCohen-Gadol AA, DiLuna ML, Bannykh SI, Piepmeier JM, Spencer DD. Non-enhancing de novo glioblastoma: report of two cases. Neurosurgical Review 2004, 27: 281-285. PMID: 15449198, DOI: 10.1007/s10143-004-0346-5.
- Surgery for Third Ventricular TumorsJohnson R, Baehring J, Piepmeier J. Surgery for Third Ventricular Tumors. Neurosurgery Quarterly 2003, 13: 207-225. DOI: 10.1097/00013414-200309000-00006.
- Transcallosal approach for tumors of the lateral and third ventricles.Kasowski H, Piepmeier J. Transcallosal approach for tumors of the lateral and third ventricles. Neurosurgical FOCUS 2001, 10: e3. PMID: 16724821, DOI: 10.3171/foc.2001.10.6.4.
- Patterns of functional magnetic resonance imaging activation in association with structural lesions in the rolandic region: a classification system.Carpentier A, Constable R, Schlosser M, de Lotbinière A, Piepmeier J, Spencer D, Awad I. Patterns of functional magnetic resonance imaging activation in association with structural lesions in the rolandic region: a classification system. Journal Of Neurosurgery 2001, 94: 946-54. PMID: 11409524, DOI: 10.3171/jns.2001.94.6.0946.
- 715 Patterns of Motor-fMRI Activation: A Classification of PlasticityCarpentier A, Constable R, Schlosser M, Piepmeier J, Spencer D, Awad I. 715 Patterns of Motor-fMRI Activation: A Classification of Plasticity. Neurosurgery 2000, 47: 503-504. DOI: 10.1097/00006123-200008000-00063.
- A neurosurgeon's perspective on the neuropathology of low-grade gliomasPiepmeier J. A neurosurgeon's perspective on the neuropathology of low-grade gliomas. Brain Tumor Pathology 2000, 17: 85-88. PMID: 11210176, DOI: 10.1007/bf02482740.
- Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissueCollingridge D, Piepmeier J, Rockwell S, Knisely J. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiotherapy And Oncology 1999, 53: 127-131. PMID: 10665789, DOI: 10.1016/s0167-8140(99)00121-8.
- Complications and Expected Outcome of Glioma SurgeryVives K, Piepmeier J. Complications and Expected Outcome of Glioma Surgery. Journal Of Neuro-Oncology 1999, 42: 289-302. PMID: 10433111, DOI: 10.1023/a:1006163328765.
- COMMENTSPiepmeier J. COMMENTS. Neurosurgery 1999, 44: 279-279. DOI: 10.1097/00006123-199902000-00018.
- Phase I Evaluation of Preirradiation Chemotherapy with Carmustine and Cisplatin and Accelerated Radiation Therapy in Patients with High-grade GliomasPiepmeier J. Phase I Evaluation of Preirradiation Chemotherapy with Carmustine and Cisplatin and Accelerated Radiation Therapy in Patients with High-grade Gliomas. Neurosurgery 1999, 44: 73-73. DOI: 10.1097/00006123-199901000-00039.
- Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.Bracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. Journal Of Neurosurgery 1998, 89: 699-706. PMID: 9817404, DOI: 10.3171/jns.1998.89.5.0699.
- Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow upBracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Neurosurgical FOCUS 1998, 5: e1. DOI: 10.3171/foc.1998.5.3.1.
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord InjuryBRACKEN M, SHEPARD M, HOLFORD T, LEO-SUMMERS L, ALDRICH E, FAZL M, FEHLINGS M, HERR D, HITCHON P, MARSHALL L, NOCKELS R, PASCALE V, PEROT P, PIEPMEIER J, SONNTAG V, WAGNER F, WILBERGER J, WINN H, YOUNG W. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury. Survey Of Anesthesiology 1998, 42: 197. DOI: 10.1097/00132586-199808000-00011.
- Manganese-metalloporphyrin (ATN-10) as a Tumor-localizing Agent: Magnetic Resonance Imaging and Inductively Coupled Plasma Atomic Emission Spectroscopy Study with Experimental Brain TumorsPiepmeier J. Manganese-metalloporphyrin (ATN-10) as a Tumor-localizing Agent: Magnetic Resonance Imaging and Inductively Coupled Plasma Atomic Emission Spectroscopy Study with Experimental Brain Tumors. Neurosurgery 1998, 42: 1337-1337. DOI: 10.1097/00006123-199806000-00084.
- Effects of Prelesioned Peripheral Nerve Graft on Nerve Regeneration in the Rat Spinal CordPiepmeier J. Effects of Prelesioned Peripheral Nerve Graft on Nerve Regeneration in the Rat Spinal Cord. Neurosurgery 1998, 42: 1356-1356. DOI: 10.1097/00006123-199806000-00096.
- Expression of c-Fos Protein in the Spinal Cord after Brachial Plexus Injury: Comparison of Root Avulsion and Distal Nerve TransectionPiepmeier J. Expression of c-Fos Protein in the Spinal Cord after Brachial Plexus Injury: Comparison of Root Avulsion and Distal Nerve Transection. Neurosurgery 1998, 42: 1362-1362. DOI: 10.1097/00006123-199806000-00100.
- The Role of Preoperative Adjuvant Treatment in the Management of Esthesioneuroblastoma: The University of Virginia ExperiencePiepmeier J. The Role of Preoperative Adjuvant Treatment in the Management of Esthesioneuroblastoma: The University of Virginia Experience. Neurosurgery 1998, 42: 1037-1037. DOI: 10.1097/00006123-199805000-00048.
- Excision Repair Cross-complementing Rodent Repair Deficiency Gene 2 Expression and Chloroethylnitrosourea Resistance in Human Glioma Cell LinesPiepmeier J. Excision Repair Cross-complementing Rodent Repair Deficiency Gene 2 Expression and Chloroethylnitrosourea Resistance in Human Glioma Cell Lines. Neurosurgery 1998, 42: 1119-1119. DOI: 10.1097/00006123-199805000-00096.
- Telomerase Activity in Human GliomasPiepmeier J. Telomerase Activity in Human Gliomas. Neurosurgery 1998, 42: 1125-1125. DOI: 10.1097/00006123-199805000-00101.
- Biology of Neurological Recovery and Functional Restoration after Spinal Cord InjuryPiepmeier J. Biology of Neurological Recovery and Functional Restoration after Spinal Cord Injury. Neurosurgery 1998, 42: 707-707. DOI: 10.1097/00006123-199804000-00009.
- Survival and Functional Status after Resection of Recurrent Glioblastoma MultiformePiepmeier J. Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme. Neurosurgery 1998, 42: 723-723. DOI: 10.1097/00006123-199804000-00019.
- Heat-induced Apoptosis in Human Glioblastoma Cell Line A172Piepmeier J. Heat-induced Apoptosis in Human Glioblastoma Cell Line A172. Neurosurgery 1998, 42: 849-849. DOI: 10.1097/00006123-199804000-00093.
- Survival and Toxicity of an Allogeneic Cytokine-secreting Fibroblast Vaccine in the Central Nervous SystemPiepmeier J. Survival and Toxicity of an Allogeneic Cytokine-secreting Fibroblast Vaccine in the Central Nervous System. Neurosurgery 1998, 42: 340-340. DOI: 10.1097/00006123-199802000-00076.
- Platelet-derived Growth Factor and Its Receptor Expression in Human OligodendrogliomasPiepmeier J. Platelet-derived Growth Factor and Its Receptor Expression in Human Oligodendrogliomas. Neurosurgery 1998, 42: 346-346. DOI: 10.1097/00006123-199802000-00082.
- Polarographic measurement of oxygen tension in human brain gliomaCollingridge D, Piepmeier J, Knisely J, Rockwell S. Polarographic measurement of oxygen tension in human brain glioma. International Journal Of Radiation Oncology • Biology • Physics 1998, 42: 267. DOI: 10.1016/s0360-3016(98)80386-6.
- Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro studyYoshida D, Piepmeier J, Bergenheim T, Henriksson R, Teramoto A. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study. British Journal Of Cancer 1998, 77: 21-25. PMID: 9459141, PMCID: PMC2151249, DOI: 10.1038/bjc.1998.4.
- Stereotactic Radiosurgery for Brain MetastasesObedian E, deLotbiniere A, Haffty B, Piepmeier J, Fischer D, Knisely J. Stereotactic Radiosurgery for Brain Metastases. 1997, 2: 78-85. DOI: 10.1159/000062267.
- Tumors of the Lateral VentricleSun P, Piepmeier J. Tumors of the Lateral Ventricle. Neurosurgery Quarterly 1997, 7: 286-300. DOI: 10.1097/00013414-199712000-00005.
- Low-grade gliomas: Introduction and overviewPiepmeier J, Christopher S. Low-grade gliomas: Introduction and overview. Journal Of Neuro-Oncology 1997, 34: 01-03. PMID: 9210048, DOI: 10.1023/a:1005798901779.
- Low-grade gliomas of chronic epilepsy: A distinct clinical and pathological entityBartolomei J, Christopher S, Vives K, Spencer D, Piepmeier J. Low-grade gliomas of chronic epilepsy: A distinct clinical and pathological entity. Journal Of Neuro-Oncology 1997, 34: 79-84. PMID: 9210054, DOI: 10.1023/a:1005711321343.
- Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997, 277: 1597-604. PMID: 9168289, DOI: 10.1001/jama.277.20.1597.
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled TrialBracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA 1997, 277: 1597-1604. DOI: 10.1001/jama.1997.03540440031029.
- 1023 Stereotactic radiosurgery for brain metastasesObedian E, deLotbiniere A, Haffty B, Piepmeier J, Fischer D, Knisely J. 1023 Stereotactic radiosurgery for brain metastases. International Journal Of Radiation Oncology • Biology • Physics 1997, 39: 227. DOI: 10.1016/s0360-3016(97)80743-2.
- Tumors and approaches to the lateral ventriclesPiepmeier J. Tumors and approaches to the lateral ventricles. Journal Of Neuro-Oncology 1996, 30: 267-274. PMID: 8943102, DOI: 10.1007/bf00177278.
- Targeting microtubule-associated proteins in glioblastoma: A new strategy for selective therapyPiepmeier J, Pedersen P, Yoshida D, Greer C. Targeting microtubule-associated proteins in glioblastoma: A new strategy for selective therapy. Annals Of Surgical Oncology 1996, 3: 543-549. PMID: 8915486, DOI: 10.1007/bf02306087.
- Estramustine in malignant gliomaBergenheim A, Henriksson R, Piepmeier J, Yoshida D. Estramustine in malignant glioma. Journal Of Neuro-Oncology 1996, 30: 81-89. PMID: 8865006, DOI: 10.1007/bf00177446.
- In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate.Yoshida D, Piepmeier J, Teramoto A. In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate. Neurosurgery 1996, 39: 360-6. PMID: 8832674, DOI: 10.1097/00006123-199608000-00025.
- BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.Jaworski D, Kelly G, Piepmeier J, Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Research 1996, 56: 2293-8. PMID: 8625302.
- Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.Piepmeier J, Susan Christopher R, Spencer D, Byrne T, Kim J, Knisel J, Lacy J, Tsukerman L, Makuch R. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 1996, 38: 872-8; discussion 878-9. PMID: 8727811, DOI: 10.1097/00006123-199605000-00002.
- A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brainHalperin E, Herndon J, Schold S, Brown M, Vick N, Cairncross J, Macdonald D, Gaspar L, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Paleologos N, Burger P, Bentel G, Friedman A. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal Of Radiation Oncology • Biology • Physics 1996, 34: 793-802. PMID: 8598355, DOI: 10.1016/0360-3016(95)02025-x.
- In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor.Piepmeier J, Rabidou N, Schold S, Bitonti A, Prakash N, Bush T. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor. Cancer Research 1996, 56: 359-61. PMID: 8542592.
- Benign Cerebral Glioma Volumes I & II (in slipcase cover)Piepmeier J. Benign Cerebral Glioma Volumes I & II (in slipcase cover). Neurosurgery 1995, 37: 1226-1227. DOI: 10.1227/00006123-199512000-00029.
- Verapamil treatment attenuates immunoreactive GFAP at cerebral cortical lesion siteKlepper S, Naftolin F, Piepmeier J. Verapamil treatment attenuates immunoreactive GFAP at cerebral cortical lesion site. Brain Research 1995, 695: 245-249. PMID: 8556338, DOI: 10.1016/0006-8993(95)00825-b.
- Management of low-grade gliomas: radiation therapy at time of recurrence.Piepmeier JM, Gunel M. Management of low-grade gliomas: radiation therapy at time of recurrence. Clinical Neurosurgery 1995, 42: 495-507. PMID: 8846614.
- Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and AstrocytesYoshida D, Cornell-Bell A, Piepmeier J. Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and Astrocytes. Neurosurgery 1994, 34: 863-868. DOI: 10.1097/00006123-199405000-00012.
- Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes.Yoshida D, Cornell-Bell A, Piepmeier J. Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes. Neurosurgery 1994, 34: 863-7; discussion 867-8. PMID: 8052384, DOI: 10.1227/00006123-199405000-00012.
- Estramustine sensitizes human glioblastoma cells to irradiation.Yoshida D, Piepmeier J, Weinstein M. Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Research 1994, 54: 1415-7. PMID: 8137240.
- A phase III randomized prospective trial of external beam radiotherapy (ERT), mitomycin C (MITO), BCNU, and 6-mercaptopurine (6-MP) for the treatment of adults with anaplastic glioma of the brainHalperin E, Herndon J, Schold S, Brown M, Vick N, Caimcross G, Macdonald D, Gaspar L, Dropcho E, Rosenfeld S, Morawetz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Burger P, Friedman A, Consortium C. A phase III randomized prospective trial of external beam radiotherapy (ERT), mitomycin C (MITO), BCNU, and 6-mercaptopurine (6-MP) for the treatment of adults with anaplastic glioma of the brain. International Journal Of Radiation Oncology • Biology • Physics 1994, 30: 214. DOI: 10.1016/0360-3016(94)90730-7.
- Low-Grade Astrocytomas May Arise from Different Astrocyte LineagesPiepmeier J, Fried I, Makuch R. Low-Grade Astrocytomas May Arise from Different Astrocyte Lineages. Neurosurgery 1993, 33: 627-632. DOI: 10.1097/00006123-199310000-00010.
- Low-grade astrocytomas may arise from different astrocyte lineages.Piepmeier J, Fried I, Makuch R. Low-grade astrocytomas may arise from different astrocyte lineages. Neurosurgery 1993, 33: 627-32. PMID: 8232801, DOI: 10.1227/00006123-199310000-00010.
- Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma CellsPiepmeier J, Keefe D, Weinstein M, Yoshida D, Zielinski J, Lin T, Chen Z, Naftolin F. Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma Cells. Neurosurgery 1993, 32: 422???431. DOI: 10.1097/00006123-199303000-00014.
- Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells.Piepmeier J, Keefe D, Weinstein M, Yoshida D, Zielinski J, Lin T, Chen Z, Naftolin F. Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells. Neurosurgery 1993, 32: 422-30; discussion 430-1. PMID: 8384327, DOI: 10.1227/00006123-199303000-00014.
- Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.Bracken M, Shepard M, Collins W, Holford T, Baskin D, Eisenberg H, Flamm E, Leo-Summers L, Maroon J, Marshall L, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. Journal Of Neurosurgery 1992, 76: 23-31. PMID: 1727165, DOI: 10.3171/jns.1992.76.1.0023.
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryBRACKEN M, SHEPARD M, COLLINS W, HOLFORD T, YOUNG W, BASKIN D, EISENBERG H, FLAMM E, LEOSUMMERS L, MAROON J, MARSHALL L, PEROT P, PIEPMEIER J, SONNTAG V, WAGNER F, WILBERGER J, WINN H. A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury. Survey Of Anesthesiology 1991, 35: 50. DOI: 10.1097/00132586-199102000-00048.
- Surgical Management of Lateral Ventricular TumorsPiepmeier J, Sass K. Surgical Management of Lateral Ventricular Tumors. 1991, 333-335. DOI: 10.1007/978-94-011-3152-0_59.
- The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas.Hait W, Byrne T, Piepmeier J, Durivage H, Choudhury S, Davis C, Gates J. The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas. Cancer Research 1990, 50: 6636-40. PMID: 1698540.
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryBracken M, Shepard M, Collins W, Holford T, Young W, Baskin D, Eisenberg H, Flamm E, Leo-Summers L, Maroon J, Marshall L, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H. A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury. New England Journal Of Medicine 1990, 322: 1405-1411. PMID: 2278545, DOI: 10.1056/nejm199005173222001.
- Malignant Glioma of the Optic Chiasm Eight Years After Radiotherapy for ProlactinomaHufnagel T, Kim J, Lesser R, Miller J, Abrahams J, Piepmeier J, Manuelidis E. Malignant Glioma of the Optic Chiasm Eight Years After Radiotherapy for Prolactinoma. JAMA Ophthalmology 1988, 106: 1701-1705. PMID: 3196211, DOI: 10.1001/archopht.1988.01060140873031.
- Late neurological changes following traumatic spinal cord injury.Piepmeier J, Jenkins N. Late neurological changes following traumatic spinal cord injury. Journal Of Neurosurgery 1988, 69: 399-402. PMID: 3404238, DOI: 10.3171/jns.1988.69.3.0399.
- Primary leptomeningeal sarcomatosis. Case report.Thibodeau L, Ariza A, Piepmeier J. Primary leptomeningeal sarcomatosis. Case report. Journal Of Neurosurgery 1988, 68: 802-5. PMID: 3357038, DOI: 10.3171/jns.1988.68.5.0802.
- Desmoplastic fibroma of parietal bone simulating eosinophilic granuloma. Case report.Hufnagel T, Artiles C, Piepmeier J, Kier L, Kim J. Desmoplastic fibroma of parietal bone simulating eosinophilic granuloma. Case report. Journal Of Neurosurgery 1987, 67: 449-51. PMID: 3612277, DOI: 10.3171/jns.1987.67.3.0449.
- Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres.Piepmeier J. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. Journal Of Neurosurgery 1987, 67: 177-81. PMID: 3598677, DOI: 10.3171/jns.1987.67.2.0177.
- Cardiovascular abnormalities accompanying acute spinal cord injury in humans: Incidence, time course and severityLehmann K, Lane J, Piepmeier J, Batsford W. Cardiovascular abnormalities accompanying acute spinal cord injury in humans: Incidence, time course and severity. Journal Of The American College Of Cardiology 1987, 10: 46-52. PMID: 3597994, DOI: 10.1016/s0735-1097(87)80158-4.
- The Spinal Cord Injury Problem—A ReviewCOLLINS W, PIEPMEIER J, OGLE E. The Spinal Cord Injury Problem—A Review. Journal Of Neurotrauma 1986, 3: 317-331. PMID: 3555851, DOI: 10.1089/cns.1986.3.317.
- A phase I trial of naloxone treatment in acute spinal cord injury.Flamm E, Young W, Collins W, Piepmeier J, Clifton G, Fischer B. A phase I trial of naloxone treatment in acute spinal cord injury. Journal Of Neurosurgery 1985, 63: 390-7. PMID: 3894597, DOI: 10.3171/jns.1985.63.3.0390.
- Intracranial Adenocystic Carcinoma Presenting as a Primary Brain TumorPiepmeier J, Virapongse C, Kier L, Kim J, Greenberg A. Intracranial Adenocystic Carcinoma Presenting as a Primary Brain Tumor. Neurosurgery 1983, 12: 348-352. PMID: 6302554, DOI: 10.1227/00006123-198303000-00021.
- Intracranial Adenocystic Carcinoma Presenting as a Primary Brain Tumor.Piepmeier J, Virapongse C, Kier L, Kim J, Greenberg A. Intracranial Adenocystic Carcinoma Presenting as a Primary Brain Tumor. Neurosurgery 1983, 12: 348. DOI: 10.1097/00006123-198303000-00021.
- Laminar distributions of 2-deoxyglucose uptake in the rat spinal cord following electrical stimulation of the sciatic nervePiepmeier J, Kauer J, Greer C. Laminar distributions of 2-deoxyglucose uptake in the rat spinal cord following electrical stimulation of the sciatic nerve. Brain Research 1983, 259: 167-171. PMID: 6824931, DOI: 10.1016/0006-8993(83)91083-1.
- Delayed Post-traumatic Extracerebral HematomasPIEPMEIER J, WAGNER F. Delayed Post-traumatic Extracerebral Hematomas. Journal Of Trauma And Acute Care Surgery 1982, 22: 455-460. PMID: 7086910, DOI: 10.1097/00005373-198206000-00003.
- Metrizamide-enhanced CT for evaluation of brainstem tumors.Glanz S, Geehr R, Duncan C, Piepmeier J. Metrizamide-enhanced CT for evaluation of brainstem tumors. American Journal Of Roentgenology 1980, 134: 821-4. PMID: 6767372, DOI: 10.2214/ajr.134.4.821.
- Piepmeier J, Thaiyananthan, T, Ocal, E: Principles of Neurosurgical Therapy. Practice and Principles of Neuro-oncology, Baehring J Piepmeier J (eds), 2006Piepmeier J, Thaiyananthan, T, Ocal, E: Principles of Neurosurgical Therapy. Practice and Principles of Neuro-oncology, Baehring J Piepmeier J (eds), 2006